Camille Bedrosian, VP, Chief Medical Officer at Ariad, holds 0.00 shares in Ariad (Ticker: ARIA), holds 35.79K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds ― shares in Crinetics Pharmaceuticals (Ticker: CRNX). Most recently, Camille Bedrosian ― shares of Ariad on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Camille Bedrosian?
The percentage of profitable transactions made by Camille Bedrosian is ―.
What is the average return per transaction made by Camille Bedrosian?
The average return per transaction made by Camille Bedrosian is ―.
What stocks does Camille Bedrosian hold?
Camille Bedrosian holds: ARIA, RARE, CRNX stocks.
What was Camille Bedrosian’s latest transaction?
Camille Bedrosian latest transaction was an Uninformative Buy of ―.
What was Camille Bedrosian's most profitable transaction?
Camille Bedrosian’s most profitable transaction was an Informative Sell of RARE stock on October 16, 2020. The return on the trade was -33.10%.
What is Camille Bedrosian's role in Ariad?
Camille Bedrosian's role in Ariad is VP, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.